MDAI
Spectral AI, Inc. (NASDAQ)
Healthcare — Medical Devices
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images. Spectral AI, Inc. is headquartered in Dallas, Texas.
Price History
Fundamentals
| Market Cap | $56.65M |
| P/E Ratio (TTM) | - |
| Forward P/E | -1.89 |
| EPS (TTM) | $-0.53 |
| Dividend Yield | - |
| Profit Margin | -81.96% |
| Revenue Growth | -40.50% |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | $5.42 |
| Analysts | 3 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 44.4 |
| Beta | 1.15 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $3.21 |
| 52-Week Low | $1.18 |
| 50-Day Avg | $2.03 |
| 200-Day Avg | $1.81 |
| Avg Volume | 650.3K |
| Volume | 313.4K |
Performance Analysis
BEARISHMDAI is flashing more cautionary signals — investors should monitor closely.
Recent News
Last updated: Jul 02, 2026 13:19 UTC
Back to Screener Export Report